Vincristine and corticosteroids as first-line treatment of Kasabach-Merritt syndrome in kaposiform hemangioendothelioma

Journal of Cutaneous Medicine and Surgery

Volumn 13, Issue 3, 2009, Pages 155-159

  Drucker, Aaron M ^a,b   Pope, Elena ^a   Mahant, Sanjay ^a   Weinstein, Miriam ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; FIBRINOGEN; MEPREDNISONE; PREDNISOLONE; PREDNISONE; RANITIDINE; TRANEXAMIC ACID; VINCRISTINE;

ANAMNESIS; ARTICLE; ARTIFICIAL EMBOLISM; CASE REPORT; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG PULSE THERAPY; ECHOGRAPHY; FEMALE; HEMANGIOENDOTHELIOMA; HOSPITAL READMISSION; HUMAN; INFANT; KAPOSIFORM HEMANGIOENDOTHELIOMA; KASABACH MERRITT SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PETECHIA; PRIORITY JOURNAL; SKIN BRUISING; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT DURATION;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOPSY; BLOOD COAGULATION DISORDERS; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HEMANGIOENDOTHELIOMA; HUMANS; INFANT, NEWBORN; SKIN; SYNDROME; VINCRISTINE; XERODERMA PIGMENTOSUM;

EID: 67651163771     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2008.08006     Document Type: Article

References (16)

1. el-Dessouky M, Azmy AF, Raine PA, et al. Kasabach-Merritt syndrome. J Pediatr Surg 1988;23:109-11.
2. Shin HY, Ryu KH, Ahn HS. Stepwise multimodal approach in the treatment of Kasabach-Merritt syndrome. Pediatr Int 2000;42: 620-4.
3. Wananukul S, Nuchprayoon I, Seksarn P. Treatment of Kasabach-Merritt syndrome: a stepwise regimen of prednisolone, dipyridamole, and interferon. Int J Dermatol 2003;42:741-8.
4. Hall GW. Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol 2001;112:851-62.
5. Thomson K, Pinnock R, Teague L, et al. Vincristine for the treatment of Kasabach-Merritt syndrome: recent New Zealand case experience. N Z Med J 2007;120:U2418.
6. Haisley-Royster C, Enjolras O, Frieden IJ, et al. Kasabach-Merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol 2002;24:459-62.
7. Enjolras O, Wassef M, Mazoyer E, et al. Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas. J Pediatr 1997; 130:631-40.
8. Zukerberg LR, Nickoloff BJ, Weiss SW. Kaposiform hemangioendothelioma of infancy and childhood. an aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 1993;17:321-8.
9. Lyons LL, North PE, Mac-Moune Lai F, et al. Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 2004;28:559-68.
10. Maguiness S, Guenther L. Kasabach-Merritt syndrome. J Cutan Med Surg 2002;6:335-9.
11. Alvarez-Mendoza A, Lourdes TS, Ridaura-Sanz C, et al. Histopathology of vascular lesions found in Kasabach-Merritt syndrome: review based on 13 cases. Pediatr Dev Pathol 2000;3: 556-60.
12. Sarkar M, Mulliken JB, Kozakewich HP, et al. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 1997;100: 1377-86.
13. Ozsoylu S, Irken G, Gurgey A. High dose intravenous methyl-prednisolone for Kassabach-Merritt syndrome. Eur J Pediatr 1989; 148:403-5.
14. Hsiao CC, Chen CC, Ko SF, et al. A case of axillary kaposiform hemangioendothelioma resembles a soft tissue sarcoma. J Pediatr Hematol Oncol 2005;27:59-8.
15. Enjolras O, Mulliken JB, Wassef M, et al. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol 2000;42:225-35.
16. Canadian Pharmacists Association. Vincristine [product monograph]. Available at: http://www.e-cps.ca (Accessed May 4, 2008).